Moderna

Pt. here for first dose of pfizer vaccine. Requested to sit by aid post vaccination for anxiety. Pt. complaint of chest pain without difficulty breathing. EMS contacted and pt. cleared to finish observation without incidence.

moderna clinic - Patient sat for a bit after vaccine - fainted when got up to leave. I heard the commotion from the pharmacy while i was giving a vaccine. Patient had signed up online for the vaccine with the date of birth 6-20-2001 (showing 19 years of age). Patient came to quickly after fainting - felt dizzy, nauseated, warm and blurred vision (seeing spots). Patient did not hit her head during fall. EMS came to check her out. Took blood pressure and pulse - within normal limits for patients age. Being that she's 14 and received Moderna instead of Pfizer that could have been the reason. Patient faulted age during online sign up stating she was 19. I checked with the mom the day after the incident - patient feels fine - no flu like symptoms or feeling dizzy, nauseated or blurred vision.

Patient became dizzy and very pale in the waiting area post vaccine. 11:29AM layed patient down in cot with an ice pack. 11:36 Patients color returned in her face. B/P 99/58, pulse 67, O2 98% and patient states feeling better. 11:38 BP 100/57 Pulse 66, and O2 98. 11:42 Patient sitting position now, and denies dizziness. Drank some water. B/P 100/57. 11:50 Patient stood up and denies any complaints. Patient states she passed out as a young child after an injection. Patient had no food this morning before her appointment. Advised to eat and hydrate before next vaccine, and to lay down for injection.

When doing initial assessment on 14 y/o F skin color pale cool classy. Complaining of nausea/vomiting went unresponsive with eyes rolling back. Increased voice level to arousal. Assisted pt to W/C with assistance to stand pt to cot. 4 sets of vitals with return of Pink warm dry skin. Orthostatics were done with a positive sustained heart rate while standing. Walked patient out to car without incident. Recommended if recurring syncope, fevers, N/V/D TO call 911 or go to Urgent Care.

Fainting episode; Dehydration; Received 1st Moderna dose at age 14; This spontaneous case was reported by a pharmacist and describes the occurrence of SYNCOPE (Fainting episode) in a 14-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 25-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-May-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Received 1st Moderna dose at age 14). On an unknown date, the patient experienced SYNCOPE (Fainting episode) (seriousness criterion medically significant) and DEHYDRATION (Dehydration). On 25-May-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Received 1st Moderna dose at age 14) had resolved. At the time of the report, SYNCOPE (Fainting episode) and DEHYDRATION (Dehydration) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered SYNCOPE (Fainting episode) to be not related. No further causality assessments were provided for PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Received 1st Moderna dose at age 14) and DEHYDRATION (Dehydration). No concomitant medications were provided. No treatment medications were provided. Company Comment: This report refers to a case of product administered to patient of inappropriate age (14- year old) for mRNA-1273 (lot number 016C21A) with associated AEs reported as syncope and dehydration. Most recent FOLLOW-UP information incorporated above includes: On 10-Jun-2021: Follow-up received on 10 June 2021.Follow-up letter uploaded. New information included added events, including serious event of fainting. On 11-Jun-2021: Follow-up received on 11 June 2021.General tab information was updated (like information regarding the person completing form). In patient tab patient's height and weight was added.In product tab anatomical location was added.Events like syncope and dehydration were added in events tab.; Sender's Comments: This report refers to a case of product administered to patient of inappropriate age (14- year old) for mRNA-1273 (lot number 016C21A) with associated AEs reported as syncope and dehydration.

Pre-syncope. Chest tightness/short of breath. Sternal Chest pain. Symptoms started 30 minutes after vaccination. Serial vitals and exam x 2 were normal. Symptoms resolved after another 60 minutes of observation.

I do not know the exact date of the first or second Moderna Vaccine. I am the PICU attending who cared for the patient after her cardiac arrest which we believe was about 3-4 days after her second Moderna Vaccine

Female 15-year old client received her first Pfizer shot (Lot# EW0185) at 15:02. She was accompanied by her mother and 12-year-old sister, who was also vaccinated at the same station with her. Client received her shot first and waited while her sister received her shot. After both girls were vaccinated, they were walking with their mother down the hallway to the observation room. RN1 stated that from the opposite end of the hallway she saw client?s knees buckle. RN1 walked toward client to ask if she was OK. Client straightened herself out, slumped onto her mother?s shoulder, and rolled onto her mother, who guided client to the floor. At 15:09 Lead RN heard client fall to the floor, went out to the client, and radioed for EMT assistance. Client was conscious and turned her face up. Client?s mother stated client passed out for 2-3 seconds and that her head did not hit the floor. Client?s mother stated that she cushioned her fall. Client was breathing adequately, appeared pale in face and lips, and stated she was OK. Lead RN and RN1 kept client lying on the floor and elevated her legs on a chair. EMT1 & EMT2 arrived at 15:10 and checked client?s pulse (HR: 74). Client denied head, neck, and back pain. Client was alert & oriented times 3 (person, place, & event). Client stated she was OK to stand up and sit in a wheelchair. Wheeled client to extra vacant breakroom where client vitals were taken by EMT2 at 15:17 (BP: 124/60, HR: 96). EMT1?s assessment found the client exhibited good circulation, sensation, and motor function in all 4 extremities. Client denied chest pain, shortness of breath, and nausea & vomiting. Client was leaning forward in the wheelchair resting her elbows on her lap. She stated she does not remember becoming nonresponsive and that she felt dizzy when lying her head back. Client stated she has a history of anxiety and panic attacks and is currently taking Prozac. Client stated she felt hot. Client?s mother stated client ate a full lunch at 12:35. At 15:20 Lead RN provided client with a bottle of water. Lead RN & EMT also observed client?s color returning to her face at that time. Client sat upright and stated that she felt better and was alert & oriented times 4. Client and mother declined going to the hospital and calling 911 for evaluation. At 15:23 client was wheeled to the observation room with her mother and sister where she remained seated in the wheelchair for 30 minutes for additional observation by EMT1. At 1600 EMT1 took client vitals while she was seated (BP: 116/82, HR: 68, RR: 16). EMT1 took client vitals again while having client stand (BP: 120/86, HR: 72, RR: 16). Client and mother stated they were OK to go home. Client and mother were instructed by Lead RN to follow up with HCP if client experienced any additional symptoms after going home and to call 911 if client experienced SOB or any difficulties breathing. Lead RN and EMT observed client leave the facility walking with a steady gait with her mother and sister.

Palpitations and chest pain Seen in ER on 7/8/21 and admitted overnight with rising troponin levels, improved by next day. Diagnosis of myocarditis related to COVID19 vaccine

The patient was given Modern instead of Pfizer for their second dose. 4 hours after injection (6pm), patient complained of and was admitted to a hospital ICU floor with high fever, rapid heart rate, and arrhythmia.